Targeted Therapy

In these videos, Koyal Jain, MD, MPH, FASN, associate professor of medicine and director, nephrology and hypertension training program at UNC School of Medicin, discusses the latest advancements in glomerular diseases.

Asporin has been discovered as a potential new target that may be used when developing therapeutic interventions for pulmonary arterial hypertension, according to a University of California, Los Angeles (UCLA) press release.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the individualized sequential therapies provided to patients based on the breast cancer subtype, genomics and other factors.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the approvals of antibody-drug conjugates and oral targeted agents that improve outcomes among patients with breast cancer.